Neurological and cognitive impairment in long-term survivors of small cell lung cancer.
Burt, Paul A
AffiliationICRF Medical Oncology Unit, Western General Hospital, Edinburgh, U.K.
MetadataShow full item record
AbstractDespite its effectiveness in reducing the rate of brain metastases, the role of prophylactic cranial irradiation (PCI) in the management of small cell lung cancer (SCLC) remains controversial because of concern about radiation-induced neurological morbidity. In order to evaluate morbidity and its impact on quality of life 64 patients surviving > or = 2 years in remission were recalled for assessment. 52 had received PCI. Most of the patients were well: 95% had performance status < or = 1 and nine out of 37 neurological examinations were abnormal. On neuropsychometric testing, only 19% of patients performed at the level expected for their age and intellectual ability on all four tests used. Fifty-four per cent of patients were impaired on two or more of the tests, suggesting a significant degree of measurable cognitive dysfunction. The number of patients who had not received PCI was insufficient for comparative analysis with the number who had, but among those treated with PCI, patients receiving 8 Gy in 1 fraction appeared less impaired than those receiving higher radiation doses in multiple fractions. The study showed that neuropsychometric testing is acceptable to patients, can be administered by non-psychologists in the clinic and is sensitive to otherwise undetected deficits of cognitive function in this patient population. Prospective evaluation of PCI should include neuropsychometric testing.
CitationNeurological and cognitive impairment in long-term survivors of small cell lung cancer. 1994, 30A (8):1067-74 Eur. J. Cancer
JournalEuropean Journal of Cancer
- Neurocognitive function in patients with small cell lung cancer : effect of prophylactic cranial irradiation.
- Authors: Grosshans DR, Meyers CA, Allen PK, Davenport SD, Komaki R
- Issue date: 2008 Feb 1
- [Neurological and cognitive impairment in long-term survivors of small cell lung cancer].
- Authors: Schnabel K
- Issue date: 1995 Apr
- Late neurological complications after prophylactic cranial irradiation in patients with small-cell lung cancer: the Toronto experience.
- Authors: Lishner M, Feld R, Payne DG, Sagman U, Sculier JP, Pringle JF, Yeoh JL, Evans WK, Shepherd FA, Maki E
- Issue date: 1990 Feb
- Clinical neurological outcome and quality of life among patients with limited small-cell cancer treated with two different doses of prophylactic cranial irradiation in the intergroup phase III trial (PCI99-01, EORTC 22003-08004, RTOG 0212 and IFCT 99-01).
- Authors: Le Péchoux C, Laplanche A, Faivre-Finn C, Ciuleanu T, Wanders R, Lerouge D, Keus R, Hatton M, Videtic GM, Senan S, Wolfson A, Jones R, Arriagada R, Quoix E, Dunant A, Prophylactic Cranial Irradiation (PCI) Collaborative Group.
- Issue date: 2011 May
- Practice guideline on prophylactic cranial irradiation in small-cell lung cancer.
- Authors: Kotalik J, Yu E, Markman BR, Evans WK, Cancer Ontario Practice Guidelines Initiative Lung Cancer Disease Site Group.
- Issue date: 2001 Jun 1